Retaglutide is a innovative GLP-1 receptor agonist currently under study for the control of type 2 diabetes. This drug works by mimicking the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone https://reganeoov765192.blogdeazar.com/39319938/semaglutide-a-potential-solution-for-diabetes